ÂÜÀòÂÒÂ×

Nathaniel Dahan is an Associate Partner of Syncona Investment Management Ltd.

Before joining Syncona, Nathaniel was part of the Life Sciences M&A Consulting team at Deloitte, focusing on preparation and execution of large pharma and medtech acquisitions and separations. His background includes strategy execution consulting in pharma, healthcare, and other industries, as well as strategic communications for biotech and medtech start-ups.

Nathaniel has a PhD in Biomedical Engineering from University College London and was also a postdoctoral researcher at Imperial College London and King's College London.